IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

FDA scaling back API facility inspections in US; Socma asks FDA to ensure frequency of inspections does not exceed three years

4:27 AM MDT | May 30, 2014 | Deepti Ramesh

The Bulk Pharmaceuticals Task Force (BPTF), an affiliate of Socma, issued a letter on 27 May to the US Food and Drug Administration (FDA) asking that the agency ensure the frequency of inspections for any domestic active pharmaceutical ingredient (API) manufacturer remains consistent. It was recently disclosed that the FDA would be scaling back by nearly 40%, the number of domestic API inspections it plans to conduct in fiscal years 2014 and 2015, in order to increase the number of foreign inspections. BPTF, which is an association for manufacturers of APIs...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa